Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04253184 · ClinicalTrials.gov registry record
Micra AV Transcatheter Pacing System Post-Approval Registry
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 802
- Enrollment target
NCT04253184: Completed study, sponsored by Medtronic.
NCT04253184 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 802 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04253184 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 802 participants
- Enrollment target
Study Summary
Medtronic is sponsoring the Micra AV Registry using the Micra AV system for continued surveillance of chronic atrioventricular synchronous pacing as intended, through the collection of data based on routine clinical care practice, following commercial release. The Micra AV Registry is conducted within Medtronic's Product Surveillance Registry (PSR) platform.
Primary Outcome
To characterize the rate of pacemaker syndrome resulting in a system revision at 3-years post-implant.
Interventions
- DEVICE Micra AV Transcatheter Pacing System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 802 participants |
| Start Date | 2020-02-08 |
| Est. Completion | 2026-01-14 |
What the finished NCT04253184 record still lists
NCT04253184 is an observational study that tracks outcomes without assigning an intervention. The registered 802 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Micra AV Transcatheter Pacing System is the first listed.
NCT04253184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04253184 about?
NCT04253184 is a clinical study titled "Micra AV Transcatheter Pacing System Post-Approval Registry". Medtronic is sponsoring the Micra AV Registry using the Micra AV system for continued surveillance of chronic atrioventricular synchronous pacing as intended, through the collection of data based on routine clinical care practice, following commercial release. The Micra AV Registry is conducted wit...
What is the current status of trial NCT04253184?
This trial is currently completed. The enrollment target is 802 participants. The study started on 2020-02-08. Estimated completion is 2026-01-14.
What interventions are being tested in trial NCT04253184?
The interventions under investigation include: Micra AV Transcatheter Pacing System (DEVICE).
Who is sponsoring clinical trial NCT04253184?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03524430 · 801 participants · NA
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI